Oncimmune Holdings Plc (ONC.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
(Values in thousands)
| 08-2024 | 08-2023 | 05-2021 | 05-2020 | 05-2019 | |
| Sales | 2,739 | 1,152 | 3,722 | 509 | 171 |
| Cost of Goods | 1,508 | 360 | 865 | 537 | 1,030 |
| Gross Profit | 1,231 | 792 | 2,857 | -28 | -859 |
| Operating Expenses | 4,448 | 5,160 | 8,074 | 10,025 | 7,779 |
| Operating Income | -3,217 | -4,368 | -5,217 | -10,053 | -8,638 |
| Interest Expense | 711 | 516 | 837 | 626 | 11 |
| Other Income | -47 | -1,044 | 358 | 896 | 101 |
| Pre-tax Income | -3,975 | -5,928 | -5,696 | -9,783 | -8,548 |
| Income Tax | -477 | 223 | -1,068 | -1,324 | -536 |
| Net Income Continuous | -3,498 | -6,151 | -4,628 | -8,459 | -8,012 |
| Net Income Discontinuous | -130 | 10,255 | N/A | N/A | N/A |
| Net Income | $-3,628 | $4,104 | $-4,628 | $-8,459 | $-8,012 |
| EPS Basic Total Ops | -0.05 | 0.06 | -0.07 | -0.13 | -0.13 |
| EPS Basic Continuous Ops | -0.05 | -0.08 | -0.07 | -0.13 | -0.13 |
| EPS Basic Discontinuous Ops | 0.00 | 0.14 | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.05 | 0.06 | -0.07 | -0.13 | -0.13 |
| EPS Diluted Continuous Ops | -0.05 | -0.08 | -0.07 | -0.13 | -0.13 |
| EPS Diluted Discontinuous Ops | 0.00 | 0.14 | N/A | N/A | N/A |
| EBITDA(a) | $-3,001 | $-4,431 | $-4,119 | $-8,657 | $-8,298 |